R. K. Agrawal

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

Joanne Haviland, John R. Owen, John Dewar et al. · The Lancet Oncology · 2013 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Charlotte E. Coles, Clare Griffin, Anna M. Kirby et al. · The Lancet · 2017 · 612 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

Adrian Murray Brunt, Joanne Haviland, Mark Sydenham et al. · Journal of Clinical Oncology · 2020 · 300 citations · Full text

Medicine, Oncology, Radiation Oncology +8

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

Christopher Poole, Helena Earl, Louise Hiller et al. · New England Journal of Medicine · 2006 · 189 citations · Full text

Medicine, Oncology, Pharmacology +16

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

David Cameron, James P. Morden, Peter Canney et al. · The Lancet Oncology · 2017 · 74 citations · Full text

Medicine, Oncology, Pharmacology +15